UG Healthcare Corporation Limited (SGX: 8K7)
Singapore
· Delayed Price · Currency is SGD 0.125
-0.004 (-3.10%)
At close: Oct 11, 2024
UG Healthcare Corporation Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 115.21 | 115.21 | 101.13 | 232.6 | 338.4 | 144.21 | Upgrade
|
| Revenue Growth (YoY) | 13.91% | 13.91% | -56.52% | -31.27% | 134.66% | 57.24% | Upgrade
|
| Cost of Revenue | 89.34 | 89.34 | 99.69 | 148.21 | 142.24 | 101.69 | Upgrade
|
| Gross Profit | 25.87 | 25.87 | 1.45 | 84.39 | 196.16 | 42.52 | Upgrade
|
| Selling, General & Admin | 32.49 | 32.49 | 26.57 | 33.22 | 40.37 | 17.72 | Upgrade
|
| Operating Expenses | 32.49 | 32.49 | 26.57 | 33.22 | 40.37 | 17.72 | Upgrade
|
| Operating Income | -6.63 | -6.63 | -25.12 | 51.17 | 155.79 | 24.8 | Upgrade
|
| Interest Expense | -1.28 | -1.28 | -0.92 | -0.81 | -0.6 | -1.99 | Upgrade
|
| Interest & Investment Income | - | - | 2.15 | 0.43 | 0.11 | 0.16 | Upgrade
|
| Earnings From Equity Investments | -0.08 | -0.08 | 0.56 | 0.1 | 3.58 | 1.16 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.25 | -3.25 | 0.37 | - | 0.99 | -5.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.15 | 2.15 | -0.08 | -2.15 | -0.46 | -0.77 | Upgrade
|
| EBT Excluding Unusual Items | -9.09 | -9.09 | -23.03 | 48.74 | 159.4 | 18.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.02 | - | - | Upgrade
|
| Asset Writedown | - | - | -5.33 | - | - | - | Upgrade
|
| Pretax Income | -9.09 | -9.09 | -28.36 | 48.76 | 159.4 | 18.06 | Upgrade
|
| Income Tax Expense | -0.31 | -0.31 | -1.4 | 8.96 | 39.46 | 2.97 | Upgrade
|
| Earnings From Continuing Operations | -8.78 | -8.78 | -26.96 | 39.8 | 119.94 | 15.09 | Upgrade
|
| Minority Interest in Earnings | 2.73 | 2.73 | 6.23 | -3 | -1.18 | -1.68 | Upgrade
|
| Net Income | -6.06 | -6.06 | -20.73 | 36.8 | 118.77 | 13.4 | Upgrade
|
| Net Income to Common | -6.06 | -6.06 | -20.73 | 36.8 | 118.77 | 13.4 | Upgrade
|
| Net Income Growth | - | - | - | -69.02% | 786.17% | 434.58% | Upgrade
|
| Shares Outstanding (Basic) | 624 | 624 | 624 | 620 | 611 | 588 | Upgrade
|
| Shares Outstanding (Diluted) | 624 | 624 | 624 | 620 | 611 | 592 | Upgrade
|
| Shares Change (YoY) | - | - | 0.58% | 1.43% | 3.24% | 2.11% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.03 | 0.06 | 0.19 | 0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.03 | 0.06 | 0.19 | 0.02 | Upgrade
|
| EPS Growth | - | - | - | -69.45% | 759.42% | 425.58% | Upgrade
|
| Free Cash Flow | -30.17 | -30.17 | -48.99 | 33.21 | 63.19 | 7.7 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.08 | 0.05 | 0.10 | 0.01 | Upgrade
|
| Dividend Per Share | - | - | - | 0.003 | 0.004 | 0.002 | Upgrade
|
| Dividend Growth | - | - | - | -21.18% | 70.59% | 164.44% | Upgrade
|
| Gross Margin | 22.45% | 22.45% | 1.43% | 36.28% | 57.97% | 29.48% | Upgrade
|
| Operating Margin | -5.75% | -5.75% | -24.84% | 22.00% | 46.04% | 17.20% | Upgrade
|
| Profit Margin | -5.26% | -5.26% | -20.50% | 15.82% | 35.10% | 9.29% | Upgrade
|
| Free Cash Flow Margin | -26.19% | -26.19% | -48.44% | 14.28% | 18.67% | 5.34% | Upgrade
|
| EBITDA | -2.76 | -2.76 | -22.41 | 54.21 | 158.28 | 26.89 | Upgrade
|
| EBITDA Margin | -2.39% | -2.39% | -22.16% | 23.31% | 46.77% | 18.65% | Upgrade
|
| D&A For EBITDA | 3.87 | 3.87 | 2.71 | 3.05 | 2.49 | 2.09 | Upgrade
|
| EBIT | -6.63 | -6.63 | -25.12 | 51.17 | 155.79 | 24.8 | Upgrade
|
| EBIT Margin | -5.75% | -5.75% | -24.84% | 22.00% | 46.04% | 17.20% | Upgrade
|
| Effective Tax Rate | - | - | - | 18.38% | 24.75% | 16.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.